This is the authors' abstract. We don't add key points for this paper.
Composites which combine biocompatible polymers and hydroxyapatite are unique materials with regards to their mechanical properties and bioactivity in the development of temporary bone‐fixation devices. Nanocomposites based on a biocompatible and amphiphilic triblock copolymer of poly(l‐lactide) (PLLA) and poly(ethylene oxide) (PEO) —PLLA‐b‐PEO‐b‐PLLA— and neat (nHAp) or PEO‐modified (nHAp@PEO) hydroxyapatite nanoparticles were prepared by dispersion in benzene solutions, followed by freeze‐drying and injection moulding processes. The morphology of the copolymers of a PEO block dispersed throughout a PLLA matrix was not changed with addition of the nanofillers. The nHAp particles were spherical and, after modification, the nHAp@PEO nanoparticles were partially agglomerated. In the nanocomposites, these particles characteristics remained unchanged, and the nHAp particles and nHAp@PEO agglomerates were uniformly dispersed through the copolymer matrix. These particles acted as nucleating agents, with nHAp@PEO being more efficient. The incorporation of nHAp increased both the reduced elastic modulus (∼22%) and the indentation hardness (∼15%) in comparison to the copolymer matrix, as determined by nanoindentation tests, while nHAp@PEO addition resulted in lower increments of these mechanical parameters. The incorporation of untreated nHAp was, therefore, more beneficial with regards to the mechanical properties, since the amphiphilic PLLA‐b‐PEO‐b‐PLLA matrix was already efficient for nHAp nanoparticles dispersion.
No takes yet. Share an insight, caveat, or question.
Loiola et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: